REVB News

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI

Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)

Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development

Kontigo Raises $20M Seed Round to Build the Bank of the Future - A Fast-growing Stablecoin Neobank

Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting

PTS Announces Official Launch of PMN on Republic -- Japan's First Compliant STO Offered in the United States

Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date